The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 14, 2025
Filed:
Nov. 27, 2019
Applicant:
Eirgen Pharma Ltd., Waterford, IE;
Inventors:
Bruce Peter Connop, Toronto, CA;
Dorothy Melissa Lynn Spencer, Toronto, CA;
Jagatraj Singh, Toronto, CA;
Pawel Dominik Buczek, Chapel Hill, NC (US);
Cale Michael Halbleib, Apex, NC (US);
Donald Edmund Kerkow, Durham, NC (US);
Assignee:
EirGen Pharma Ltd., Waterford, IE;
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/605 (2006.01); A61J 1/05 (2006.01); A61K 9/00 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/60 (2017.01); A61P 3/10 (2006.01); C07K 1/02 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/605 (2013.01); A61J 1/05 (2013.01); A61K 9/0019 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 47/60 (2017.08); A61P 3/10 (2018.01); C07K 1/02 (2013.01); A61K 38/00 (2013.01);
Abstract
The present invention relates to GLP-1 and/or glucagon receptor agonists (for example, oxyntomodulin peptide analogs), pharmaceutically acceptable salts thereof, formulations comprising the same, and uses thereof for treating diabetes and/or obesity or associated diseases or disorders.